
Many psychotropics on the market are generic forms and essentially similar products. Bioequivalence is the method used in order to demonstrate the therapeutic equi-valence between the reference drug and the new product. The principles, methods and limits of these studies are presented and illustrated by some examples for CNS drugs.
Anti-Anxiety Agents, Therapeutic Equivalency, Depression, Humans, Hypnotics and Sedatives, Central Nervous System Stimulants, Anxiety, Antidepressive Agents
Anti-Anxiety Agents, Therapeutic Equivalency, Depression, Humans, Hypnotics and Sedatives, Central Nervous System Stimulants, Anxiety, Antidepressive Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
